Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2

The 2019 coronavirus disease (COVID-19) caused by SARS-CoV-2 virus infection has posed a serious danger to global health and the economy. However, SARS-CoV-2 medications that are specific and effective are still being developed. Honokiol is a bioactive component from Magnoliae officinalis Cortex wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yong, Meng, Jie-Ru, Liu, Jia-Zheng, Xu, Ting, Zheng, Zhi-Yuan, Jiang, Zhi-Hong, Bai, Li-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471451/
https://www.ncbi.nlm.nih.gov/pubmed/34577585
http://dx.doi.org/10.3390/ph14090885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471451/
https://www.ncbi.nlm.nih.gov/pubmed/34577585
http://dx.doi.org/10.3390/ph14090885

Ejemplares similares